Number of Chains

SCOPe

Number of Protein Chains:4

PDB Entries

PDB ID OPM Mutant Chain Formula Resolution HETNAM
Amino Acid sequence SCOPe Family Level CATH Homology Level
1ao6 [A] [A] [A] 2.5
1bj5 [A] [A] [A] 2.5
MYR:MYRISTIC ACID
1bke [A] [A] [A] 3.15
B3I:2,3,5-TRIIODOBENZOIC ACID
MYR:MYRISTIC ACID
1bm0 [A] [A] [A] 2.5
1e78 [A] [A] [A] 2.6
1e7a [A] [A] [A] 2.2
PFL:2,6-BIS(1-METHYLETHYL)PHENOL
1e7b [A] [A] [A] 2.38
HLT:2-BROMO-2-CHLORO-1,1,1-TRIFLUOROETHANE
1e7c [A] [A] [A] 2.4
HLT:2-BROMO-2-CHLORO-1,1,1-TRIFLUOROETHANE
MYR:MYRISTIC ACID
1e7e [A] [A] [A] 2.5
DKA:DECANOIC ACID
1e7f [A] [A] [A] 2.43
DAO:LAURIC ACID
1e7g [A] [A] [A] 2.5
MYR:MYRISTIC ACID
1e7h [A] [A] [A] 2.43
PLM:PALMITIC ACID
1e7i [A] [A] [A] 2.7
STE:STEARIC ACID
1gni [A] [A] [A] 2.4
OLA:OLEIC ACID
1gnj [A] [A] [A] 2.6
ACD:ARACHIDONIC ACID
1h9z [A] [A] [A] 2.5
MYR:MYRISTIC ACID
RWF:R-WARFARIN
1ha2 [A] [A] [A] 2.5
MYR:MYRISTIC ACID
SWF:S-WARFARIN
1hk1 [A] [A] [A] 2.65
T44:3,5,3___sq___,5___sq___-TETRAIODO-L-THYRONINE
1hk2 [A] [A] [A] 2.8
T44:3,5,3___sq___,5___sq___-TETRAIODO-L-THYRONINE
1hk3 [A] [A] [A] 2.8
T44:3,5,3___sq___,5___sq___-TETRAIODO-L-THYRONINE
1hk4 [A] [A] [A] 2.4
MYR:MYRISTIC ACID
T44:3,5,3___sq___,5___sq___-TETRAIODO-L-THYRONINE
1hk5 [A] [A] [A] 2.7
MYR:MYRISTIC ACID
T44:3,5,3___sq___,5___sq___-TETRAIODO-L-THYRONINE
1n5u [A] [A] [A] 1.9
HEM:PROTOPORPHYRIN IX CONTAINING FE
MYR:MYRISTIC ACID
1o9x [A] [A] [A] 3.2
HEM:PROTOPORPHYRIN IX CONTAINING FE
MYR:MYRISTIC ACID
1tf0 [AB] [AB] [AB] 2.7
CIT:CITRIC ACID
DKA:DECANOIC ACID
1uor [A] [A] [A] 2.8
1ysx [A] [A] [A] SOLUTION NMR
4EB:4-({2-[(2,4-DIMETHYLPHENYL)SULFANYL]ETHYL}AMINO)-N-[(4___sq___-FLUORO-1,1___sq___-BIPHENYL-4-YL)CARBONYL]-3-NITROBENZENESULFONAMIDE
2bx8 [A] [A] [A] 2.7
AZQ:AZAPROPAZONE
2bxa [A] [A] [A] 2.35
C1F:3-CARBOXY-4-METHYL-5-PROPYL-2-FURANPROPIONIC
2bxb [A] [A] [A] 3.2
OPB:4-BUTYL-1-(4-HYDROXYPHENYL)-2-PHENYLPYRAZOLIDINE-3,5-DIONE
2bxe [A] [A] [A] 2.95
1FL:5-(2,4-DIFLUOROPHENYL)-2-HYDROXY-BENZOIC ACID
2bxf [A] [A] [A] 2.95
DZP:7-CHLORO-1-METHYL-5-PHENYL-1,3-DIHYDRO-2H-1,4-BENZODIAZEPIN-2-ONE
2bxg [A] [A] [A] 2.7
IBP:IBUPROFEN
2bxh [A] [A] [A] 2.25
IOS:3-SULFOOXY-1H-INDOLE
2bxl [A] [A] [A] 2.6
DIU:2-HYDROXY-3,5-DIIODO-BENZOIC ACID
MYR:MYRISTIC ACID
2bxm [A] [A] [A] 2.5
IMN:INDOMETHACIN
MYR:MYRISTIC ACID
2bxn [A] [A] [A] 2.65
IDB:3-[5-[(3-CARBOXY-2,4,6-TRIIODO-PHENYL)CARBAMOYL]PENTANOYLAMINO]-2,4,6-TRIIODO-BENZOIC ACID
MYR:MYRISTIC ACID
2bxo [A] [A] [A] 2.6
MYR:MYRISTIC ACID
OPB:4-BUTYL-1-(4-HYDROXYPHENYL)-2-PHENYLPYRAZOLIDINE-3,5-DIONE
2bxp [A] [A] [A] 2.3
MYR:MYRISTIC ACID
P1Z:4-BUTYL-1,2-DIPHENYL-PYRAZOLIDINE-3,5-DIONE
2esg [A2B2C] [A2B2C] [A2B2C] SOLUTION SCATTERING
2i2z [A] [A] [A] 2.7
ALY:N(6)-ACETYLLYSINE
MYR:MYRISTIC ACID
SAL:2-HYDROXYBENZOIC ACID
2i30 [A] [A] [A] 2.9
MYR:MYRISTIC ACID
SAL:2-HYDROXYBENZOIC ACID
2vue [A] [A] [A] 2.42
BLA:BILIVERDINE IX ALPHA
2xvq [A] [A] [A] 2.9
9DS:DANSYL-L-SARCOSINE
2xvu [A] [A] [A] 2.6
9DN:DANSYL-L-ASPARAGINE
2xw0 [A] [A] [A] 2.4
9NF:DANSYL-L-PHENYLALANINE
2xw1 [A] [A] [A] 2.5
9NV:DANSYL-L-NORVALINE
2ydf [A] [A] [A] 2.75
IO3:IOPHENOXIC ACID
3a73 [A] [A] [A] 2.19
MYR:MYRISTIC ACID
PJ2:(5Z,12Z,15S)-15-HYDROXY-11-OXOPROSTA-5,9,12-TRIEN-1-OICACID
3b9l [A] [A] [A] 2.6
AZZ:3___sq___-AZIDO-3___sq___-DEOXYTHYMIDINE
MYR:MYRISTIC ACID
3b9m [A] [A] [A] 2.7
AZZ:3___sq___-AZIDO-3___sq___-DEOXYTHYMIDINE
MYR:MYRISTIC ACID
SAL:2-HYDROXYBENZOIC ACID
3jry [A] [A] [A] 2.3
SO4:SULFATE ION
3lu6 [A] [A] [A] 2.7
IMX:[(1R,2R)-2-{[(5-FLUORO-1H-INDOL-2-YL)CARBONYL]AMINO}-2,3-DIHYDRO-1H-INDEN-1-YL]ACETIC ACID
3lu7 [A] [A] [A] 2.8
IPX:4-[(1R,2R)-2-{[(5-FLUORO-1H-INDOL-2-YL)CARBONYL]AMINO}-2,3-DIHYDRO-1H-INDEN-1-YL]BUTANOIC ACID
PO4:PHOSPHATE ION
3lu8 [A] [A] [A] 2.6
IQX:N-[5-(5-{[(2,4-DIMETHYL-1,3-THIAZOL-5-YL)SULFONYL]AMINO}-6-FLUOROPYRIDIN-3-YL)-4-METHYL-1,3-THIAZOL-2-YL]ACETAMIDE
3tdl [A] [A] [A] 2.6
11D:11-({[5-(DIMETHYLAMINO)NAPHTHALEN-1-YL]SULFONYL}AMINO)UNDECANOIC ACID
MYR:MYRISTIC ACID
3uiv [A] [A] [A] 2.2
308:(3S,5S,7S)-TRICYCLO[3.3.1.1~3,7~]DECAN-1-AMINE
MYR:MYRISTIC ACID
4e99 [A] [A] [A] 2.3
P8S:HEPTADECAFLUORO-1-OCTANESULFONIC ACID
4emx [A] [A] [A] 2.3
CL:CHLORIDE ION
4g03 [A] [A] [A] 2.22
4g04 [A] [A] [A] 2.3
4hgm [AB] [AB] [AB] 2.34
ACE:ACETYL GROUP
EDO:1,2-ETHANEDIOL
4iw1 [A] [A] [A] 2.56
FRU:BETA-D-FRUCTOFURANOSE
FUD:D-FRUCTOSE
PO4:PHOSPHATE ION
4iw2 [A] [A] [A] 2.41
GLC:ALPHA-D-GLUCOPYRANOSE
GLO:D-GLUCOSE
PO4:PHOSPHATE ION
4k71 [ABC] [ABC] [ABC] 2.4
SO4:SULFATE ION
4l8u [A] [A] [A] 2.01
9AZ:(2S)-2-[1-AMINO-8-(HYDROXYMETHYL)-9-OXO-9,11-DIHYDROINDOLIZINO[1,2-B]QUINOLIN-7-YL]-2-HYDROXYBUTANOIC ACID
MYR:MYRISTIC ACID
4l9k [A] [A] [A] 2.4
EHF:(2S)-2-HYDROXY-2-[8-(HYDROXYMETHYL)-9-OXO-9,11-DIHYDROINDOLIZINO[1,2-B]QUINOLIN-7-YL]BUTANOIC ACID
4l9q [A] [A] [A] 2.7
9TP:(5S,5AR,8AR,9R)-9-(4-HYDROXY-3,5-DIMETHOXYPHENYL)-8-OXO-5,5A,6,8,8A,9-HEXAHYDROFURO[3___sq___,4___sq___:6,7]NAPHTHO[2,3-D][1,3]DIOXOL-5-YL 4,6-O-(THIOPHEN-2-YLMETHYLIDENE)-BETA-D-GLUCOPYRANOSIDE
4la0 [A] [A] [A] 2.4
198:R-BICALUTAMIDE
4lb2 [A] [A] [A] 2.8
DM5:IDARUBICIN
4lb9 [A] [A] [A] 2.7
EVP:(5S,5AR,8AR,9R)-9-(4-HYDROXY-3,5-DIMETHOXYPHENYL)-8-OXO-5,5A,6,8,8A,9-HEXAHYDROFURO[3___sq___,4___sq___:6,7]NAPHTHO[2,3-D][1,3]DIOXOL-5-YL 4,6-O-[(1R)-ETHYLIDENE]-BETA-D-GLUCOPYRANOSIDE
MYR:MYRISTIC ACID
4s1y [A] [A] [A] 3.16
CPT:CISPLATIN
4z69 [A] [A] [A] 2.19
DIF:2-[2,6-DICHLOROPHENYL)AMINO]BENZENEACETIC ACID
F15:PENTADECANOIC ACID
PLM:PALMITIC ACID
5gix [A] [A] [A] 2.8
6WF:14-PIPERIDIN-1-YL-11-OXA-13$L^{3}-THIA-15,16$L^{4}-DIAZA-12$L^{3}-FERRATETRACYCLO[8.7.0.0^{2,7}.0^{12,16}]HEPTADECA-1(10),2(7),3,5,8,13,16-HEPTAENE
PLM:PALMITIC ACID
5giy [A] [A] [A] 2.54
7GE:PENTAKIS(CHLORANYL)-(1~{H}-INDAZOL-2-IUM-2-YL)RUTHENIUM(1-)
PLM:PALMITIC ACID
5id7 [A] [A] [A] 2.26
6A4:(4S)-2-SULFANYLIDENE-4-[(TETRADECANOYLOXY)METHYL]-1,3,2LAMBDA~5~-DIOXAPHOSPHOLANE-2-THIOLATE
PEG:DI(HYDROXYETHYL)ETHER
PGE:TRIETHYLENE GLYCOL
5ijf [A] [A] [A] 2.65
UNL:UNKNOWN LIGAND
ZN:ZINC ION
5ujb [A] [A] [A] 2.7
6AK:4-{8-CHLORO-11-[3-(4-CHLORO-3,5-DIMETHYLPHENOXY)PROPYL]-1-OXO-7-(1,3,5-TRIMETHYL-1H-PYRAZOL-4-YL)-4,5-DIHYDRO-1H-[1,4]DIAZEPINO[1,2-A]INDOL-2(3H)-YL}-1-METHYL-1H-INDOLE-6-CARBOXYLIC ACID
PO4:PHOSPHATE ION
5x52 [A] [A] [A] 3.01
AME:N-ACETYLMETHIONINE
OCA:OCTANOIC ACID (CAPRYLIC ACID)
PO4:PHOSPHATE ION
5yb1 [A] [A] [A] 2.62
8ZR:~{N},~{N},12-TRIMETHYL-3$L^{3}-THIA-1$L^{4},5,6$L^{4}-TRIAZA-2$L^{3}-CUPRATRICYCLO[6.4.0.0^{2,6}]DODECA-1(8),3,6,9,11-PENTAEN-4-AMINE
PLM:PALMITIC ACID
5yoq [A] [A] [A] 2.65
CLT:4-PHENYL-BUTANOIC ACID
PO4:PHOSPHATE ION
5z0b [A3] [A3] [A3] 2.17
1PE:PENTAETHYLENE GLYCOL
CSO:S-HYDROXYCYSTEINE
EIC:LINOLEIC ACID
OCA:OCTANOIC ACID (CAPRYLIC ACID)
PEG:DI(HYDROXYETHYL)ETHER
PG4:TETRAETHYLENE GLYCOL
PGE:TRIETHYLENE GLYCOL
PLM:PALMITIC ACID
SO4:SULFATE ION
TRP:TRYPTOPHAN
6a7p [A] [A] [A] 2.28
9SC:7-[4-[4-[2,3-BIS(CHLORANYL)PHENYL]PIPERAZIN-1-YL]BUTOXY]-3,4-DIHYDRO-1H-QUINOLIN-2-ONE
K:POTASSIUM ION
PG4:TETRAETHYLENE GLYCOL
PO4:PHOSPHATE ION
6ezq [A] [A] [A] 2.39
C7K:12-[(4-NITRO-2,1,3-BENZOXADIAZOL-7-YL)AMINO]DODECANOICACID
6hsc [A] [A] [A] 1.9
EDO:1,2-ETHANEDIOL
GOQ:8-METHOXY-6-NITRO-NAPHTHO[1,2-E][1,3]BENZODIOXOLE-5-CARBOXYLIC ACID
MYR:MYRISTIC ACID
6l4k [A] [A] [A] 2.09
E5O:2-BROMANYL-9-ETHYL-~{N},~{N},7-TRIMETHYL-3-THIA-1$L^{4},5,6$L^{4},10-TETRAZA-2$L^{4}-CUPRATRICYCLO[6.4.0.0^{2,6}]DODECA-1(8),4,6,9,11-PENTAEN-4-AMINE
PLM:PALMITIC ACID
6m4r [A] [A] [A] 2.49
6qio [ABCD] [ABCD] [ABCD] 1.95
CYS:CYSTEINE
JG5:(2S)-6-ACETAMIDO-2-[[2-[2-[2-[[4-CARBOXY-4-[[(4S)-4-CARBOXY-4-[[2-[2-[2-[4-[16-(1H-TETRAZOL-5-YL)HEXADECANOYLSULFAMOYL]BUTANOYLAMINO]ETHOXY]ETHOXY]ACETYL]AMINO]BUTANOYL]AMINO]BUTANOYL]AMINO]ETHOXY]ETHOXY]ACETYL]AMINO]HEXANOIC ACID
MES:2-(N-MORPHOLINO)-ETHANESULFONIC ACID
6qip [ABC] [ABC] [ABC] 2.45
CYS:CYSTEINE
HDW:(2~{S})-6-[2-(2-HYDROXYETHYLSULFANYL)ETHANOYLAMINO]-2-[2-[2-[2-[[(4~{R})-5-OXIDANYL-5-OXIDANYLIDENE-4-[[(4~{S})-5-OXIDANYL-5-OXIDANYLIDENE-4-[2-[2-[2-[4-[16-(2~{H}-1,2,3,4-TETRAZOL-5-YL)HEXADECANOYLSULFAMOYL]BUTANOYLAMINO]ETHOXY]ETHOXY]ETHANOYLAMINO]PENTANOYL]AMINO]PENTANOYL]AMINO]ETHOXY]ETHOXY]ETHANOYLAMINO]HEXANOIC ACID
MES:2-(N-MORPHOLINO)-ETHANESULFONIC ACID
6r7s [A] [A] [A] 2.21
DMS:DIMETHYL SULFOXIDE
SAS:2-HYDROXY-(5-([4-(2-PYRIDINYLAMINO)SULFONYL]PHENYL)AZO)BENZOIC ACID
SO4:SULFATE ION
6wuw [A] [A] [A] 2.2
EDO:1,2-ETHANEDIOL
MYR:MYRISTIC ACID
OCA:OCTANOIC ACID (CAPRYLIC ACID)
PG4:TETRAETHYLENE GLYCOL
UAY:7-IMINO-2-PHENYLTHIENO[3,2-C]PYRIDINE-4,6(5H,7H)-DIONE
UNL:UNKNOWN LIGAND
6yg9 [A] [A] [A] 1.89
MYR:MYRISTIC ACID
OQ5:20-[[(2~{S})-5-[2-[2-[2-[2-[2-[2-(DIETHYLAMINO)-2-OXIDANYLIDENE-ETHOXY]ETHOXY]ETHYLAMINO]-2-OXIDANYLIDENE-ETHOXY]ETHOXY]ETHYLAMINO]-1-OXIDANYL-1,5-BIS(OXIDANYLIDENE)PENTAN-2-YL]AMINO]-20-OXIDANYLIDENE-ICOSANOIC ACID
7jwn [A] [A] [A] 2.6
9KL:(2S)-2-[3-(BENZENECARBONYL)PHENYL]PROPANOIC ACID
CYS:CYSTEINE
EDO:1,2-ETHANEDIOL
JGE:(R)-KETOPROFEN
MYR:MYRISTIC ACID
*Chain Formula of OLIGAMI.
  [ ] : Polypeptide - [AB] : Protein, [ab] : Small peptide
  ( ) : Nucleic acid - (AB) : DNA, (ab) : RNA
PDL